EXHIBIT 4.2
                                                                     -----------

                            STOCK PURCHASE AGREEMENT


           THIS STOCK PURCHASE AGREEMENT is made as of the ___ day of August,
2001, by and between Able Laboratories, Inc. (the "Company"), a corporation
organized under the laws of Delaware with its principal offices at 200 Highland
Avenue, Suite 301, Needham, MA 02494, and each of the persons and entities,
severally and not jointly, whose names are set forth on the Schedule of
Purchasers attached hereto as EXHIBIT B (which persons and entities are
hereinafter collectively referred to as "Purchasers" and each individually as a
"Purchaser").

           IN CONSIDERATION of the mutual covenants contained in this Agreement,
the parties agree as follows:

           SECTION 1. Authorization of Sale of the Shares. Subject to the terms
and conditions of this Agreement, the Company has authorized the sale and
issuance to the Purchasers of the number of shares (the "Shares") of Series Q
Convertible Preferred Stock $.01 par value per share (the "Series Q Stock"), of
the Company set forth on the signature page hereof. The Series Q Stock shall
have the rights, preferences, privileges, and restrictions set forth in the
Certificate of Designation, Preferences, and Rights of Series Q Stock in the
form attached hereto as EXHIBIT A (the "Designation").

           SECTION 2. Agreement to Sell and Purchase the Shares. At the Closing
(as defined in Section 3), the Company will issue and sell the Shares to each
Purchaser, severally and not jointly, and each Purchaser will buy the number of
Shares from the Company set forth opposite such Purchasers name on EXHIBIT B,
upon the terms and conditions hereinafter set forth, at the purchase price set
forth on EXHIBIT B.

           SECTION 3. Delivery of the Shares at the Closing. The completion of
the purchase and sale of the Shares (the "Closing") shall occur simultaneously
with the execution hereof (the "Closing Date"). At the Closing, the Company will
issue to each Purchaser one or more stock certificates registered in the name of
the Purchaser, or in such nominee name(s) as designated by each Purchaser in
writing, representing the Shares. The name(s) in which the stock certificates
are to be registered are set forth in the Stock Certificate Questionnaire
attached hereto as APPENDIX I. The Company's obligation to complete the purchase
and sale of the Shares being purchased hereunder and deliver such stock
certificates to the Purchasers at the Closing shall be subject to the following
conditions, any one or more of which may be waived by the Company: (a) receipt
by the Company of (i) same-day funds in the full amount of the purchase price
for the Shares being purchased hereunder, (ii) promissory notes previously
issued by the Company in the amounts set forth on Schedule 3, for cancellation
as payment of the purchase price for the shares being purchased hereunder, (iii)
a cash advance or accruals for services rendered to the Company as set forth on
Schedule 3, or (iv) any combination of such methods of payment; and (b) the
accuracy in all material respects of the representations and warranties made by
the Purchasers and the fulfillment of those undertakings of the Purchasers to be
fulfilled prior to or at the Closing. The Purchasers' obligation to accept
delivery of such stock certificate(s) and to pay for the Shares evidenced
thereby shall be subject to the accuracy in all material respects of the
<PAGE>
representations and warranties made by the Company herein and the fulfillment of
those undertakings of the Company to be fulfilled prior to or at the Closing.

           SECTION 4. Representations, Warranties and Covenants of the Company.
The Company hereby represents and warrants to, and covenants with, the
Purchasers as follows:

           4.1 Organization and Qualification. The Company is a corporation duly
organized, validly existing and in good standing under the laws of the State of
Delaware; and the Company is duly qualified to do business as a foreign
corporation and is good standing in each other jurisdiction in which
qualification is required, except where the failure to be so qualified will not
have a Material Adverse Effect, as defined in Section 4.4.

           4.2 Authorized Capital Stock.  Immediately prior to the Closing, the
authorized capital stock of the Company consists of:

                      (i) 225,000,000 shares of Common Stock, $.01 par value per
           share, (the "Common Stock") of which 127,977,653 shares are issued
           and outstanding at the close of business on August 7, 2001; and

                      (ii) 10,000,000 shares of Preferred Stock, $.01 par value
           per share. Each series of Preferred Stock designated by the Board of
           Directors is listed on Schedule 4.2 hereto.

All subscriptions, warrants, options, convertible securities, and other rights
(contingent or other) to purchase or otherwise acquire equity securities of the
Company issued and outstanding immediately prior to the Closing, or contracts,
commitments, understandings, or arrangements by which the Company or any of its
subsidiaries is or may be obligated to issue shares of Common Stock, or
securities or rights convertible or exchangeable for shares of Common Stock, are
as set forth on Schedule 4.2 hereto. Except as set forth on Schedule 4.2, no
Common Stock nor any subscription, warrant, option, convertible security, or
other right (contingent or other) to purchase or otherwise acquire equity
securities of the Company is outstanding on the Closing Date. The issued and
outstanding shares of the Company's capital stock have been duly authorized and
validly issued, are fully paid and nonassessable, have been issued in compliance
with all applicable federal and state securities laws, and were not issued in
violation of or subject to any preemptive rights or other rights to subscribe
for or purchase securities. No holder of Common Stock is entitled to preemptive
or similar rights.

           4.3. Issuance, Sale and Delivery of the Shares. The Shares being
purchased hereunder have been duly authorized and, when issued, delivered and
paid for in the manner set forth in this Agreement, will be duly authorized,
validly issued, fully paid and nonassessable, and will be free of any liens or
encumbrances other than liens or encumbrances created or imposed upon the
Purchasers. The shares of Common Stock issuable upon conversion of the Shares
(the "Conversion Shares") have been duly and validly reserved for issuance upon
conversion of the Shares and, when so issued, will be duly authorized, validly
issued, fully paid and nonassessable shares of Common Stock, and will be free of
any liens or encumbrances or rights of first refusal other than liens or
encumbrances created by or imposed upon the Purchasers. Except as listed on
Schedule 4.3, no preemptive rights or similar rights of any stockholder of the

                                       -2-
<PAGE>
Company or any of its subsidiaries to subscribe for or purchase exist with
respect to the issuance and sale of the Shares or the issuance and delivery of
the Conversion Shares by the Company pursuant to this Agreement. Except as
contemplated by Section 7.5 of this Agreement, no further approval or authority
of the stockholders or the Board of Directors of the Company will be required
for the issuance and sale of the Shares to be sold by the Company as
contemplated herein or for the issuance and delivery of the Conversion Shares.
The Company's issuance of the Shares and the Conversion Shares shall be in
compliance with all applicable federal and state securities laws.

           4.4. Due Execution, Delivery and Performance of the Agreements. The
Company has full corporate power and authority to own and operate its properties
and assets, to enter into this Agreement and the Registration Rights Agreement
in the form attached hereto as EXHIBIT C (the "Registration Rights Agreement"
and, together with this Agreement and the Designation, the "Transaction
Documents"), to issue and sell the Shares and the Conversion Shares, and perform
the transactions contemplated by this Agreement and the Registration Rights
Agreement. The Transaction Documents have been duly authorized, and at the
Closing the Transaction Documents will have been duly executed and delivered by
the Company. The execution, delivery and performance of the Transaction
Documents by the Company and the consummation by the Company of the transactions
therein contemplated will not violate any provision of the Certificate of
Incorporation or by-laws of the Company.

           The execution, delivery and performance of the Transaction Documents
by the Company and the consummation by the Company of the transactions therein
contemplated will not result in the creation of any lien, charge, security
interest or encumbrance upon any assets of the Company pursuant to the terms or
provisions of, or conflict with, result in the breach or violation of, or
constitute, either by itself or upon notice or the passage of time or both, a
default under any material agreement, mortgage, deed of trust, lease, franchise,
license, indenture, permit or other instrument to which the Company is a party
or by which the Company or any of its properties may be bound or affected and in
each case which individually or in the aggregate would have a material adverse
effect on the condition (financial or otherwise), properties, business,
prospects, or results of operations of the Company and its subsidiaries, taken
as a whole (a "Material Adverse Effect"), or any statute or any authorization,
judgment, decree, order, rule or regulation of any court or any regulatory body,
administrative agency or other governmental body applicable to the Company or
any of its respective properties. No consent, approval, authorization or other
order of any court, regulatory body, administrative agency or other governmental
body is required for the execution and delivery of the Transaction Documents or
the consummation of the transactions contemplated by the Transaction Documents,
except for compliance with all federal and state securities laws applicable to
the offering and sale of the Shares.

           Upon its execution and delivery, and assuming the valid execution
thereof by the Purchaser, the Transaction Documents will constitute valid and
binding obligations of the Company, enforceable against the Company in
accordance with their terms, except as enforceability may be limited by
applicable bankruptcy, insolvency, reorganization, moratorium or similar laws
affecting creditors' and contracting parties' rights generally and except as
enforceability may be subject to general principles of equity (regardless of
whether such enforceability is considered in a proceeding in equity or at law).

                                       -3-
<PAGE>
           4.5 Good Standing of Subsidiaries. Each of the Company's subsidiaries
(i) is listed on Schedule 4.5, (ii) has been duly organized and is validly
existing in good standing under the laws of the jurisdiction of its
incorporation, (iii) has corporate power and authority to own, lease and operate
its properties and to conduct its business as conducted and as proposed to be
conducted, and (iv) is duly qualified and is in good standing as a foreign
corporation in each jurisdiction in which such qualification is required, except
where the failure to be so qualified will not have a Material Adverse Effect.
All of the issued and outstanding capital stock of each such subsidiary has been
duly authorized and validly issued, is duly paid and nonassessable and is owned
by the Company free and clear of any security interest, mortgage, pledge, lien,
encumbrance, claim or equity; and none of the outstanding shares of capital
stock of each such subsidiary was issued in violation of any preemptive or
similar rights of any third party.

           4.6 No Defaults. The Company is not in violation of or default under
any provision of its Certificate of Incorporation or bylaws, or other
organizational documents. Except as disclosed in the Information Documents (as
that term is defined in Section 4.17 below), neither the Company nor any of its
subsidiaries, and to the best of the Company's knowledge, no other party
thereto, is in breach of or default with respect to any provision of any
agreement, judgment, decree, order, mortgage, deed of trust, lease, franchise,
license, indenture, permit or other instrument to which the Company or any of
its subsidiaries is a party or by which the Company, any of its subsidiaries, or
any of their properties are bound; and there does not exist any state of facts
which, with notice or lapse of time or both, would constitute an event of
default as defined in such documents on the part of the Company or any of its
subsidiaries, except for such breaches and defaults that individually or in the
aggregate would not have a Material Adverse Effect. Neither the Company nor any
of its subsidiaries is in violation of any judgment, order, or decree by which
the Company, any of its subsidiaries, or their properties is bound. Neither the
Company nor any of its subsidiaries is in violation of any statute, rule, or
regulation of any governmental authority, except for such violations that
individually or in the aggregate would not have a Material Adverse Effect.

           4.7 No Actions. Except as disclosed in the Information Documents,
there are no legal or governmental actions, suits or proceedings, or
investigation pending or, to the best of the Company's knowledge, threatened to
which the Company or any of its subsidiaries is or may be a party or of which
property owned or leased by the Company or any of its subsidiaries is or may be
subject (except for litigation that individually or in the aggregate would not
have a Material Adverse Effect); and no material labor problem or labor
disturbance by the employees of the Company or any of its subsidiaries exists,
or, to the best of the Company's knowledge, is imminent. Except for the
"Stipulated Order Amending Agreed Order Of Permanent Injunction" entered in the
matter captioned United States v. Able Laboratories, Inc., Civ. Action No.
91-4916 (D.N.J.), neither the Company nor any of its subsidiaries is a party to
or subject to the provisions of any injunction, judgment, decree or order of any
court, regulatory body, administrative agency or other governmental body.

           4.8 Properties. The Company and each of its subsidiaries has, as of
the applicable dates referred to therein, good and marketable title to all the
properties and assets reflected as owned by it in the financial statements
included in the Information Documents, subject to no lien, mortgage, pledge,
charge or encumbrance of any kind except (i) those, if any, reflected in such
financial statements or listed in Schedule 4.8, or (ii) those that are not

                                       -4-
<PAGE>
material in amount and do not adversely affect the use made and currently
proposed to be made of such property by the Company or such subsidiary. The
Company and its subsidiaries hold their leased properties under valid and
binding leases. The Company and its subsidiaries own or lease all such
properties as are necessary to their operations as now conducted. Neither the
Company nor any of its subsidiaries own any real property. Any real property and
facilities held under lease by the Company and its subsidiaries are held by them
under valid, subsisting, and enforceable leases of which the Company and its
subsidiaries are in compliance.

           4.9 No Material Change. Since December 31, 2000, except as disclosed
in the Information Documents: (i) the Company and its subsidiaries have not
incurred any material liabilities or obligations, indirect or contingent, or
entered into any material verbal or written agreement or other transaction that
is not in the ordinary course of business; (ii) the Company and its subsidiaries
have not sustained any material loss or interference with their businesses or
properties from fire, flood, windstorm, accident or other calamity, whether or
not covered by insurance; (iii) the Company has not paid or declared any
dividends or other distributions with respect to its Common Stock, and the
Company and each of its subsidiaries is not in default in the payment of
principal or interest on any outstanding debt obligations, if any; (iv) there
has not been any material change in the indebtedness material to the Company or
any of its subsidiaries, other than the promissory notes issued by the Company
that are being cancelled pursuant to this Agreement or other than in the
ordinary course of business; and (v) there has not been a Material Adverse
Effect in the condition (financial or otherwise), properties, business or
results of operations of the Company or any of its subsidiaries.

           4.10    Intellectual Property.

                   (a) The Company and its subsidiaries own or have the right to
use all Intellectual Property Rights (as defined below) used by the Company and
its subsidiaries for the conduct of their respective businesses, which
Intellectual Property Rights are the only Intellectual Property Rights necessary
or required for the conduct of their respective businesses as they are currently
being conducted.

                   (b) Neither the Company nor any of its subsidiaries is in
default of its obligations to pay royalties or other amounts to other persons by
reason of the ownership or use of any Intellectual Property Rights used by the
Company and its subsidiaries for the conduct of their respective businesses.

                   (c) No Intellectual Property Right owned by the Company or
any of its subsidiaries violates or will violate any license or infringes or
will infringe any Intellectual Property Rights of another. To the best of the
Company's knowledge, no Intellectual Property Right, product or service
marketed, sold or licensed (as licensor or as licensee) by the Company or any of
its subsidiaries, violates or will violate any license or infringes or will
infringe any Intellectual Property Rights of another, nor has the Company or any
of its subsidiaries received any notice that any of the Intellectual Property
Rights used by the Company or any of its subsidiaries for the conduct of their
respective businesses, conflicts or will conflict with the rights of others.

                                       -5-
<PAGE>
                   (d) There are no claims pending or, to the best of the
Company's knowledge, threatened with respect to any Intellectual Property Rights
necessary or required for the conduct of the business of the Company or any of
its subsidiaries as currently conducted, nor, to the best of the Company's
knowledge, does there exist any basis therefor.

As used herein, the term "Intellectual Property Rights" means all patents,
trademarks, service marks, trade names, copyrights, inventions, trade secrets,
know-how, licenses, proprietary processes and formulae and applications for
patents, trademarks, service marks and copyrights.

           4.11    Compliance. The Company and each of its subsidiaries is in
possession of all permits, licenses, and other authorizations material to the
conduct of its business as currently conducted or as proposed to be conducted.
The Company has not been advised, and has no reason to believe, that the Company
or any of its subsidiaries is not conducting business in compliance with all
licenses, permits, and other authorizations material to the conduct of their
business and with all applicable laws, rules, and regulations of the
jurisdictions in which it is conducting business, except where failure to be in
compliance would not have a Material Adverse Effect.

           4.12    Taxes. The Company and each of its subsidiaries has filed all
federal, state, county and local tax returns, required to be filed by it, and
the Company and each of its subsidiaries has paid all taxes shown to be due by
such returns as well as all other taxes, assessments and governmental charges
that have become due or payable, including, without limitation, all taxes that
the Company or such subsidiary is obligated to withhold from amounts owing to
employees, creditors and third parties. The Company and its subsidiaries have
established adequate reserves for all taxes accrued but not yet payable. No
audit, action, suit, proceeding, claim, examination, deficiency, or assessment
is currently pending or, to the best of the Company's knowledge, threatened
against the Company or any of its subsidiaries. There is no tax lien (other than
for current taxes not yet due and payable), whether imposed by a Federal, state,
county, or local taxing authority, outstanding against the assets, properties or
business of the Company or any of its subsidiaries.

           4.13    Investment Company.  The Company is not regulated or required
to be registered as an "investment company" within the meaning of the Investment
Company Act of 1940, as amended.

           4.14    Integration, etc. The Company has not in the past nor will it
hereafter take any action to sell, offer for sale or solicit offers to buy any
securities of the Company that would bring the offer, issuance or sale of the
Shares, as contemplated by this Agreement, within the provisions of Section 5 of
the Securities Act of 1933, as amended (the "Securities Act"). Neither the
Company nor any of its Affiliates (as defined in Rule 501(b) of Regulation D
under the Securities Act) has directly, or through any agent, (i) sold, offered
for sale, solicited offers to buy or otherwise negotiated in respect of, any
"security" (as defined in the Securities Act) which is or could be integrated
with the sale of the Shares in a manner that would require the registration
under the Securities Act of the Shares or (ii) engaged in any form of general
solicitation or general advertising (as those terms are used in Regulation D
under the Securities Act) in connection with the offering of the Shares or in
any manner involving a public offering within the meaning of Section 4(2) of the
Act.
                                       -6-
<PAGE>
           4.15    Insurance.  The Company maintains the insurance policies
summarized on Schedule 4.15.  To the knowledge of the Company, all such
insurance policies are in full force and effect.

           4.16  Reporting Company; Listed Securities. The Company has filed all
reports and statements required to be filed by Sections 13(a) or 15(d) of the
Securities Exchange Act of 1934, as amended (the "Exchange Act"), during the two
years preceding the Closing Date on a timely basis and has been subject to such
filing requirements for such two year period. The Company's Common Stock is
quoted on the OTC Bulletin Board Market and is listed for trading on the Boston
Stock Exchange. As of the Closing Date, the Company meets all the requirements
for continued listing on the OTC Bulletin Board Market and the Boston Stock
Exchange, and to the best of the Company's knowledge, there is no stop order
suspending the trading of the Common Stock on the OTC Bulletin Board Market or
the Boston Stock Exchange or any information that would result in the Common
Shares being delisted from the OTC Bulletin Board Market or the Boston Stock
Exchange. All material agreements to which the Company is a party or to which
the property or assets of the Company are subject have been filed as exhibits to
the Information Documents as required under the Exchange Act.

           4.17 Additional Information. A true and complete copy of each report,
schedule, registration statement and definitive proxy statement filed by the
Company with the Commission under the Securities Act and the Exchange Act during
the twelve (12) months preceding the Closing Date (as such documents have since
the time of their filing been amended together with all documents incorporated
by reference therein or attached as exhibits thereto, the "Information
Documents"), which include all the documents (other than preliminary material)
that the Company was required to file with the Commission under the Exchange Act
since such date, has been made available to the Purchasers. As of their
respective dates, each Information Document and any forms, reports and other
documents filed by the Company during the period commencing on the date of this
Agreement and ending on the last date on which the Company is required to
maintain the effectiveness of the registration statement referred to in the
Registration Rights Agreement (the "Registration Statement"), complied or will
comply in all material respects with the requirements of the Securities Act or
the Exchange Act, as the case may be, and the rules and regulations of the
Commission thereunder applicable to the Information Documents or such other
forms, reports or other documents, and no Information Document contained, or
will contain at the time it was or is filed, any untrue statement of a material
fact or omitted, or will omit at the time they are filed, to state a material
fact required to be stated therein or necessary to make the statements therein,
in light of the circumstances under which they were made, not misleading. The
financial statements, together with the related notes, of the Company included
in the Information Documents comply as to form in all material respects with
applicable accounting requirements and with the published rules and regulations
of the Commission with respect thereto, have been prepared in accordance with
generally accepted accounting principles applied on a consistent basis during
the periods involved (except as may be indicated in the notes thereto or, in the
case of the unaudited statements, as permitted by the rules and regulations of
the Commission) and fairly present (subject, in the case of the unaudited
statements, to normal, recurring audit adjustments, which were not individually
or in the aggregate material) in all material respects the financial position of
the Company and its consolidated subsidiaries as at the dates thereof and their
consolidated results of operations and cash flows for the periods then ended.
There were no material liabilities, direct or indirect, fixed or contingent, of

                                       -7-
<PAGE>
the Company and its consolidated subsidiaries as of the respective dates of such
financial statements that generally accepted accounting principles would require
to be reflected therein that are not reflected therein or in the notes thereto.
Since March 31, 2001, except as disclosed in the Information Documents (i) there
has been no material change in the consolidated condition, financial or
otherwise, or operations of the Company and its consolidated subsidiaries, (ii)
except as set forth in Schedule 4.17 neither the Company nor any of its
consolidated subsidiaries has incurred any indebtedness for money borrowed or
any material liability, contingent or otherwise, except in the ordinary course
of business or entered into any material commitment or other transaction not in
the ordinary course of business, (iii) there has been no event, occurrence, or
development that has resulted or that could result in a Material Adverse Effect,
(iv) the Company has not declared or made any payment or distribution of cash or
other property to its stockholders, officers, or directors (other than in
compliance with existing compensation agreements or stock option plans) with
respect to its capital stock, or purchased, redeemed (or made any agreements to
purchase or redeem) any shares of its capital stock, and (v) the Company has not
altered its method of accounting.

           4.18    Legal Opinion.  At the Closing, the Company will cause Foley,
Hoag & Eliot LLP, counsel to the Company, to deliver a legal opinion to the
Purchasers as to the matters set forth in EXHIBIT D hereto.

           4.19 Outstanding Registration Rights. Except as described in Schedule
4.19, the Company is not a party to any contract or agreement pursuant to which
any other party or parties thereto have the right to require the Company (on a
best efforts basis or otherwise) (i) to register securities of the Company under
the Securities Act for sale by or on behalf of such party or parties or (ii) to
notify such party or parties of the Company's intention to file a registration
statement under the Securities Act and at the request of such party or parties
to include therein securities of the Company for sale by or on behalf of such
party or parties.

           4.20    Environmental and Safety Laws. To the Company's knowledge,
neither the Company nor any of its subsidiaries is in violation of any
applicable statute, law, or regulation relating to the environment or
occupational health and safety, and to its knowledge, no material expenditures
are or will be required in order to comply with any such existing statute, law,
or regulation.

           4.21    Other Adverse Facts, etc. To the best of the Company's
knowledge, there are no existing facts or circumstances that materially and
adversely affect, or (insofar as the Company can now reasonably foresee) in the
future may materially and adversely affect, the business, results of operations,
or condition, financial or otherwise, of the Company and its consolidated
subsidiaries that are not disclosed in the Information Documents or in this
Agreement or any exhibit or schedule hereto, or which are required to be
disclosed by the Company in an Information Document.

           SECTION 5.  Representations, Warranties and Covenants of the
Purchaser.

           5.1     Each Purchaser, individually and not jointly, represents and
warrants to, and covenants with, the Company that: (i) it is knowledgeable,
sophisticated and experienced in making, and is qualified to make, decisions
with respect to investments in securities representing an investment decision

                                       -8-
<PAGE>
like that involved in the purchase of the Shares, including investments in
securities issued by the Company, and has requested, received, reviewed and
understood all information it deems relevant in making an informed decision to
purchase the Shares, including, without limitation, the information contained in
the Information Documents; (ii) it acknowledges that the offering of the Shares
pursuant to this Agreement has not been reviewed by the Commission or any state
regulatory authority; (iii) it is acquiring the number of Shares set forth in
the signature page hereto, for its own account for investment only and with no
present intention of distributing any of such Shares or any arrangement or
understanding with any other persons regarding the distribution of such Shares;
(iv) it will not, directly or indirectly, offer, sell, pledge, transfer or
otherwise dispose of (or solicit any offers to buy, purchase or otherwise
acquire or take a pledge of) any of the Shares except in compliance with the
Securities Act, rules and regulations promulgated under the Securities Act and
any applicable state securities or blue sky laws; (v) it has completed or caused
to be completed the Stock Certificate Questionnaire, attached hereto as APPENDIX
I and will at the Company's request the Registration Statement Questionnaire
complete or cause to be completed the Registration Statement Questionnaire
attached hereto as APPENDIX II, for use in preparation of the Registration
Statement, and the answers thereto are true and correct as of the date hereof
and will be true and correct as of the effective date of the Registration
Statement; (vi) it has, in connection with its decision to purchase the number
of Shares set forth on the signature page hereof, not relied upon any
representations or other information (whether oral or written) other than as set
forth in the Information Documents and the representations and warranties of the
Company contained herein; (vii) it has had an opportunity to discuss this
investment with representatives of the Company and ask questions of them and
such questions have been answered to the full satisfaction of the Purchaser; and
(viii) it is an "accredited investor" within the meaning of Rule 501 of
Regulation D promulgated under the Securities Act.

           5.2    Each Purchaser, individually and not jointly, hereby covenants
with the Company not to make any sale of the Shares without satisfying the
prospectus delivery requirements under the Securities Act, if any.

           5.3  Each Purchaser, individually and not jointly, further represents
and warrants to, and covenants with, the Company that (i) the Purchaser has full
right, power, authority and capacity to enter into this Agreement and to
consummate the transactions contemplated hereby and has taken all necessary
action to authorize the execution, delivery and performance of this Agreement,
(ii) the Purchaser is duly organized, validly existing and in good standing
under the laws of its jurisdiction of organization, (iii) no consent, approval,
authorization, or other order of any court, regulatory body, administrative
agency or other governmental body that has not been obtained is required on the
part of the Purchaser for the execution and delivery of this Agreement or the
consummation of the transactions contemplated by this Agreement, and (iv) upon
the execution and delivery of this Agreement, this Agreement shall constitute a
valid and binding obligation of the Purchaser enforceable in accordance with its
terms, except as enforceability may be limited by applicable bankruptcy,
insolvency, reorganization, moratorium or similar laws affecting creditors' and
contracting parties' rights generally and except as enforceability may be
subject to general principles of equity (regardless of whether such
enforceability is considered in a proceeding in equity or at law) and (v) there
is not in effect any order enjoining or restraining the Purchaser from entering
into or engaging in any of the transactions contemplated by this Agreement.

                                       -9-
<PAGE>
           5.4 Each Purchaser, individually and not jointly, recognizes that an
investment in the Shares is speculative and involves a high degree of risk,
including a risk of total loss of the Purchaser's investment.

           5.5 Each Purchaser, individually and not jointly, represents and
warrants that all of the information provided to the Company or its agents or
representatives concerning such Purchaser's suitability to invest in the Company
and the representations and warranties contained herein, are complete, true, and
correct as of the date hereof, and understands that the Company is relying on
the statements contained herein to establish an exemption from registration
under U.S. federal and state securities laws.

           5.6 Each Purchaser, individually and not jointly, represents and
warrants that the address set forth in the signature page hereto is such
Purchaser's true and correct domicile.

           5.7 Each Purchaser, individually and not jointly, covenants to
provide the Company an updated, accurate and complete plan of distribution at
all times during which the Company is required to keep the Registration
Statement in effect.

           5.8 Each Purchaser, individually and not jointly, understands and
agrees that each certificate or other document evidencing any of the Shares
shall be endorsed with a legend in substantially the form set forth below as
well as any other legends required by applicable law, and the Purchaser
covenants that the Purchaser shall not transfer the Shares represented by any
such certificate without complying with the restrictions on transfer described
in the legends endorsed on such certificate:

           THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT
           BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS
           AMENDED ("SECURITIES ACT"), OR REGISTERED OR QUALIFIED
           UNDER ANY APPLICABLE STATE SECURITIES LAWS. THESE
           SECURITIES MAY NOT BE TRANSFERRED UNLESS (A) COVERED BY AN
           EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT
           AND REGISTERED OR QUALIFIED UNDER APPLICABLE STATE
           SECURITIES LAWS OR (B) EXEMPTIONS FROM SUCH REGISTRATION OR
           QUALIFICATION REQUIREMENTS ARE AVAILABLE. AS A CONDITION TO
           PERMITTING ANY TRANSFER OF THESE SECURITIES, THE COMPANY
           MAY REQUIRE THAT IT BE FURNISHED WITH AN OPINION OF COUNSEL
           ACCEPTABLE TO THE COMPANY TO THE EFFECT THAT NO
           REGISTRATION OR QUALIFICATION IS LEGALLY REQUIRED FOR SUCH
           TRANSFER.

           SECTION 6.Survival of Representatives and Warranties. Notwithstanding
any investigation made by any party to this Agreement, all representations and
warranties made by the Company and the Purchasers herein and in any certificates

                                      -10-
<PAGE>
or documents delivered pursuant hereto or in connection therewith shall survive
following the delivery to the Purchasers of the Shares being purchased and the
payment therefor.

           SECTION 7.  Covenants.

           7.1.   Corporate Existence. The Company will take all steps necessary
to preserve and continue the corporate existence of the Company. The Company
will comply with all applicable laws and regulations, decrees, orders,
judgements, licenses, and permits ("Applicable Laws"), except where
non-compliance with such Applicable Laws would not have a Material Adverse
Effect.

           7.2.  Reservation of Common Stock. As of the date hereof, the Company
has authorized and reserved and the Company shall continue to reserve and keep
available, free of preemptive rights, shares of Common Stock for the purpose of
enabling the Company to issue the Conversion Shares. The number of shares so
reserved shall be increased or decreased to reflect adjustments in the number of
Conversion Shares issuable upon conversion of the Shares.

           7.3.   Exchange Act Registration. The Company will maintain the
registration of its Common Stock under Section 12 of the Exchange Act, will
comply in all respects with its reporting and filing obligations under the
Exchange Act, and will not take any action or file any document (whether or not
permitted by the Exchange Act or the rules thereunder) to terminate or suspend
such registration or to terminate or suspend its reporting and filing
obligations under said Act, until the date which is two years from the Closing
Date.

           7.4. Listing of Common Stock. The Company shall prepare and file with
the Boston Stock Exchange an additional shares listing application covering a
reasonable estimate of the Conversion Shares issuable upon conversion of the
Shares and take all steps necessary to cause such shares to be approved for
listing as soon as practicable thereafter. In addition, if at any time the
number of Conversion Shares issuable upon conversion of the Shares is greater
than the number of shares of Common Stock theretofore listed on the Boston Stock
Exchange, the Company shall promptly take such action to file an additional
shares listing application covering such additional number of shares of Common
Stock.

           7.5. Increase in Authorized Shares. As such time as the Company would
be, if all outstanding Shares were immediately converted, precluded from
honoring the conversion of the Shares in full due to the unavailability of a
sufficient number of shares of authorized but unissued Common Stock, the Board
of Directors of the Company shall promptly (an in any case within 90 days from
such date) hold a stockholders meeting at which the stockholders would vote to
amend the Company's Certificate of Incorporation to increase the number of
authorized shares of Common Stock to at least a number of shares equal to the
sum of (i) all shares of Common Stock then outstanding, (ii) the number of
shares of Common Stock issuable on account of all outstanding warrants, options,
and convertible securities (other than the Shares) and on account of all shares
reserved under any stock option, stock purchase, or similar plan, and (iii) such
number of Conversion Shares as would then be issuable upon conversion of all
outstanding Shares. The Board of Directors of the Company shall recommend, and
shall otherwise use its best efforts to promptly obtain, stockholder approval of
such amendment, and the Company shall use its best efforts to cause Company

                                      -11-
<PAGE>
management to vote shares of Common Stock held by management in favor of such
amendment. During any period in which the Company does not have a sufficient
number of shares of authorized but unissued Common Stock available to convert
all outstanding Shares, the Directors of the Company agree not to convert any
Shares or exercise any stock options to purchase shares of Common Stock.

           7.6. Distribution Operations. Unless the holders of a majority of the
Shares agree to the contrary, within 90 days from the date of this Agreement the
Company will relocate its distribution operations to its facility in South
Plainfield, New Jersey, or such other location mutually agreed to by the Company
and a majority of the holders of the outstanding shares of Series Q Stock.

           7.7. Stock Option Pool. Without the prior consent of the holders of a
majority of the Shares, for as long as at least 25% of the shares of Series Q
Stock issue pursuant to this Agreement are outstanding the Company will not
increase the stock option pool for employees by more than 5,000,000 shares (as
adjusted for any stock dividends, combinations, splits, recapitalization, and
similar events).

           7.8.  Observer Rights. So long as Corporate Opportunities Funds, L.P.
and the Corporate Opportunities Fund (Institutional), L.P. ("Corporate
Opportunities Funds") own 50% or more of the number of Shares originally
purchased by them at the Closing, the Company shall allow one representative of
Corporate Opportunities Funds to attend all meetings of the Company's Board of
Directors in a nonvoting capacity, and in connection therewith, the Company
shall give such representative copies of all notices, minutes consents and other
materials, financial or otherwise, that the Company provides to its Board of
Directors, PROVIDED, THAT any such representative agrees to leave all or any
portion of a meeting of the Board of Directors in the event that, in the
reasonable good faith believe of the Board of Directors, allowing such
representative to remain in the meeting would result in a waiver of the
attorney-client privilege. The failure to provide the observer rights in this
Section 7 shall not affect the validity of any action taken by the Board.

           7.9. Use of Proceeds. The Company will apply all of the proceeds (net
of costs directly related to the preparation and negotiation of this Agreement
and the offering and sale of the Shares) derived from the sale of the Shares to
redeem indebtedness and for general working capital purposes.

           7.10. Taxes. The Company will promptly pay and discharge all lawful
taxes, assessments, and governmental charges or levies imposed on it or upon its
income or profits, or upon any of its properties, real or personal, before the
same shall become in default, as well as all lawful claims for labor, materials,
and supplies or otherwise which, if unpaid, might become a lien or charge upon
its properties or any part thereof, except where the failure to do so would not
have a Material Adverse Effect; provided, however, that the Company shall not be
required to pay or cause to be paid any such tax, assessment, charge, levy or
claim prior to institution of foreclosure proceedings if the validity thereof
shall be contested in good faith by appropriate proceedings and if the Company
shall have established reserves deemed by the Company to be adequate with
respect to such tax, assessment, charge, levy, or claim.

                                      -12-
<PAGE>
           7.11. Insurance. The Company will maintain liability, property
damage, and insurance on its insurable property against fire and other hazards
with responsible insurance carriers in the relative proportionate amounts
consistent with the Company's past practice and usually carried by reasonable
and prudent companies conducting businesses similar to that of the Company
except where the failure to do so would not have a Material Adverse Effect.

           7.12. Financial Statements and Compliance Certificates. The Company
will keep true books of record and account in which full, true, and correct
entries in accordance with generally accepted accounting principles will be made
of all dealings or transactions in relation to its business and activities. For
a period of three years after the Closing Date, or until such earlier date on
which no Shares issued and outstanding as of the Closing remain issued and
outstanding, the Company immediately upon public filing shall furnish, by email,
facsimile or overnight mail, to each holder of Shares:

                     (i) commencing with the fiscal quarter ending September 30,
           2001, a consolidated balance sheet of the Company as of the end of
           such quarter and consolidated statements of operations and cash flows
           of the Company for such quarter and for the expired portion of the
           then current fiscal year, setting forth comparable figures for the
           same quarter and expired portion of the previous fiscal year, and
           prepared and certified by the chief financial or accounting officer
           of the Company, subject to year-end audit adjustment;

                     (ii) a balance sheet of the Company as of the end of such
           fiscal year and consolidated statements of operations, stockholders'
           equity, and cash flows of the Company for such fiscal year, setting
           forth comparable figures for the previous fiscal year, all reported
           upon, and certified, by independent certified public accountants of
           nationally recognized standing;

                     (iii) with each financial statement required to be
           delivered pursuant to the provisions of paragraph (ii) above, a
           certificate of the chief financial or accounting officer of the
           Company stating that to the best of his knowledge there does not
           exist any Event of Default or any condition or event which after
           notice or lapse of time, or both, would constitute an Event of
           Default, or specifying the nature and period of existence of each
           such Event of Default, condition or event and the action the Company
           is taking or proposes to take with respect thereto; and

                     (iv) copies of all financial statements and reports sent by
           the Company to its shareholders and of all regular and periodic
           reports, if any, filed by it with the Commission pursuant to any
           statute, rule, or regulation administered by the Commission.

           7.13. Rule 144. As long as the Purchasers own Shares or Conversion
Shares, (i) the Company agrees to timely file all reports required to be filed
by the Company after the date hereof under the Securities Act and the Exchange
Act (including the reports pursuant to Section 13(a) or 15(d) of the Exchange
Act referred to in subparagraph (c)(1) of Rule 144) and the rules and
regulations adopted by the SEC thereunder), (ii) if the Company is not required
to file reports pursuant to such sections, it will prepare and furnish to the
Purchasers and make publicly available in accordance with Rule 144(c) such
information as is required for the Purchasers to sell the Shares and the
Conversion Shares under Rule 144, and (iii) the Company will take such further

                                      -13-
<PAGE>
action as any holder of Shares or Conversion Shares may reasonably request, all
to the extent required from time to time to enable such Purchaser to sell
Conversion Shares without registration under the Securities Act within the
limitation of the exemptions provided by Rule 144, including causing its
attorneys to issue and deliver any appropriate legal opinion required to permit
a Purchaser to sell Conversion Shares under Rule 144 upon receipt of appropriate
documentation relating to such sale. Upon the request of any Purchaser, the
Company shall deliver to such person a written certification of a duly
authorized officer as to whether it has complied with the foregoing
requirements.

           SECTION 8.  Registration and Transfer of Shares. The Company agrees
to maintain an office (or to appoint an agent having an office) in Needham,
Massachusetts, or such other city as the Company may designate by notice in
writing to holders of Shares, at which Shares may be surrendered for transfer
and reissuance, for exchange, replacement, conversion, or cancellation. The
Company shall keep or cause to be kept, at the office or agency so maintained, a
register or registers in which the Company or its agent shall register the names
and addresses of the holders of the Shares and shall transfer registered Shares
in accordance with this Agreement. Upon surrender for transfer of any registered
Shares duly assigned by the registered holder (or its duly authorized attorney)
to the transferee(s) thereof, and subject to satisfaction of the requirements
set forth in Section 5.8 hereof if the sale of such Shares is not registered
under the Securities Act, the Company shall execute and deliver a new registered
certificate for the Shares. No service charge shall be assessed for any
transfer, registration, reissuance, exchange, or conversion hereunder.

           SECTION 9.  Substitution of Share Certificates. Upon receipt by the
Company of evidence satisfactory to it of the loss, theft, destruction, or
mutilation of any certificate for Shares, and of indemnity satisfactory to it
(which, in the case of any original purchaser of the Shares, shall be a
contractual obligation of such purchaser) and upon surrender, at the office or
agency maintained in accordance with Section 8 hereof, and cancellation of any
certificate, if mutilated, the Company will execute and deliver a new
certificate of like tenor, in lieu of such certificate.

           SECTION 10. Event of Default. The occurrence and continuation of any
one or more of the following events shall constitute an "Event of Default"
hereunder: default shall be made in the due performance or observance of any
material covenant, agreement, or provision herein to be performed or observed by
the Company or a breach shall exist in any material representation or warranty
herein contained, and such default or breach is material and shall have
continued unabated for a period of 90 days after written notice thereof to the
Company from any holder or holders of Shares aggregating not less than 25% of
the aggregate number of the Shares then outstanding.

           SECTION 11. Expenses. Each party hereto will pay its own expenses in
connection with the transactions contemplated hereby, whether or not such
transactions shall be consummated, provided, however, that the Company shall pay
the reasonable out-of-pocket expenses (including fees of counsel) of Corporate
Opportunities Funds in connection with such transactions up to a maximum of
$20,000.

                                      -14-
<PAGE>
           SECTION 12. Broker's Fee. The Purchasers acknowledge that the Company
intends to pay to Phoenix Capital a fee in respect of the sale of the Shares to
the Purchasers. Each of the parties hereto hereby represents that, on the basis
of any actions and agreements by it, there are no other brokers or finders
entitled to compensation from the other party in connection with the sale of
Shares to the Purchasers.

           SECTION 13. Notices. All notices, requests, consents, and other
communications under this Agreement shall be in writing and shall be delivered
by hand, sent via overnight courier, sent by facsimile, or mailed by first class
certified or registered mail, return receipt requested, postage prepaid:

                       if to the Company, to:

                       Able Laboratories, Inc.
                       200 Highland Avenue, Suite 301
                       Needham, MA  02494
                       Attn:  President

                       with a copy to:

                       Foley, Hoag & Eliot LLP
                       One Post Office Square
                       Boston, MA  02109
                       Attn:  David A. Broadwin, Esq.

or to such other person at such other place as the Company shall designate to
the Purchasers in writing; and

if to the Purchasers, at the address as set forth on EXHIBIT B, or at such other
address or addresses as may have been furnished to the Company in writing.

Notices provided in accordance with this Section 13 shall be deemed delivered
(i) upon personal delivery with signature required, (ii) one Business Day after
they have been sent to the recipient by reputable overnight courier service
(charges prepaid and signature required) (iii) upon confirmation, answer back
received, of successful transmission of a facsimile message containing such
notice if sent between 9 a.m. and 5 p.m., local time of the recipient, on any
Business Day, and as of 9 a.m. local time of the recipient on the next Business
Day if sent at any other time, or (iv) three Business Days after deposit in the
mail. The term "Business Day" as used in this Section 13 shall mean any day
other than Saturday, Sunday or a day on which banking institutions are not
required to be open in The Commonwealth of Massachusetts.

           SECTION 14. Amendment and Waiver. This Agreement may be amended or
modified only upon the written consent of the Company and the holders of a
majority of the Shares then outstanding (treated as if converted and including
any Conversion Shares into which the Shares have been converted that have not
been sold to the public). The obligations of the Company and the rights of the
holders of the Shares and the Conversion Shares under this Agreement may be
waived only with the written consent of the holders of a majority of the Shares

                                      -15-
<PAGE>
(treated as if converted and including any Conversion Shares into which the
Shares have been converted that have not been sold to the public).

           SECTION 15. Changes. This Agreement may not be modified or amended
except pursuant to an instrument in writing, signed by the Company and the
Purchasers. Any provision in this Agreement to the contrary notwithstanding,
changes in or additions to this Agreement may be made, and compliance with any
covenant or condition herein set forth may be omitted, if the Company (a) shall
obtain from the holders of record of Shares aggregating not less than a majority
of the number of the Shares at the time outstanding their consent thereto in
writing and (b) shall deliver copies of such consent in writing to any such
holders of record who did not execute the same; provided, however, that without
the consent in writing of all holders of the Shares purchased pursuant to this
Agreement, no such consent shall reduce the percentage of the number of the
Shares the consent of the holders of which shall be required under this Section
15.

           SECTION 16. Headings. The headings of the various sections of this
Agreement have been inserted for convenience of reference only and shall not be
deemed to be part of this Agreement.

           SECTION 17. Severability. In case any provision contained in this
Agreement should be invalid, illegal or unenforceable in any respect, the
validity, legality and enforceability of the remaining provisions contained
herein shall not in any way be affected or impaired thereby.

           SECTION 18. Governing Law. This Agreement shall be governed by and
construed in accordance with the laws of the State of Delaware, without giving
effect to any choice of law provisions thereof.

           SECTION 19. Counterparts. This Agreement may be executed in two or
more counterparts, each of which shall constitute an original, but both of
which, when taken together, shall constitute but one instrument, and shall
become effective when one or more counterparts have been signed by each party
hereto and delivered to the other party.

           SECTION 20. Remedies. In addition to being entitled to exercise all
rights provided herein or granted by law, including recovery of damages, each of
the Purchasers will be entitled to specific performance of the obligations of
the Company under the Transaction Documents. The Company and each of the
Purchasers agree that monetary damages may not be adequate compensation for any
loss incurred by reason of any breach of the obligations under the Transaction
Documents and hereby agree to waive in any action for specific performance of
any such obligation the defense that a remedy at law would be adequate.

           SECTION 21. Confidentiality. Each Purchaser covenants and agrees to
use, and to use its best efforts to ensure that its authorized representatives
shall use, the same degree of care with the Company's "confidential information"
as such Purchaser uses to protect its own financial, confidential and
proprietary information. For purposes hereof, "confidential information"
includes all financial, confidential and proprietary information which is
provided to such Purchaser under this agreement or is otherwise provided to such
Purchaser and identified by the Company in writing to such Purchaser as being of
a confidential nature, but shall not include any information which (i) was
available to or in possession of such Purchaser or any employees thereof or any

                                      -16-
<PAGE>
beneficial owner of a partnership interest in such Purchaser (collectively
referred to herein as "Permitted Recipients") prior to the time of disclosure to
such Purchaser by the Company or its representatives, (ii) is or becomes
generally available to the public other than as a result of a disclosure by any
of such Permitted Recipients, or (iii) is or becomes available to such Permitted
Recipients on a nonconfidential basis by a third party which is not bound by a
confidentiality agreement with the Company. Notwithstanding the preceding
sentence, a Purchaser may (a) disclose such confidential information when
required by law or governmental order or regulation or when required by a
subpoena or other process, provided that such Purchaser shall use reasonable
efforts to give the Company prior written notice thereof with sufficient time to
seek a protective order or confidential treatment; (b) disclose such
confidential information to the extent necessary to enforce this Agreement; and
(c) disclose such confidential information to its attorneys, accountants,
consultants and other professionals, partners, members and affiliates to the
extent necessary to obtain their services in connection with its investment in
the Company, provided that the requirements of this Section 10.14 shall in turn
be binding on any such attorney, accountant consultant, other professional,
partner, member or affiliate.

           SECTION 22. Entire Agreement. This Agreement (including the
attachments hereto) contains the entire agreement of the parties with respect to
the subject matter hereof and supersedes and is in full substitution for any and
all prior oral or written agreements and understandings between them related to
such subject matter, and neither party hereto shall be liable or bound to the
other party hereto in any manner with respect to such subject matter by any
representations, indemnities, covenants or agreements except as specifically set
forth herein.

                     [REMAINDER OF PAGE INTENTIONALLY BLANK]














                                      -17-
<PAGE>


           IN WITNESS WHEREOF, the parties hereto have caused this Agreement to
be executed as of the date first above written by their duly authorized
representatives shown below:

                                               ABLE LABORATORIES, INC.

                                               By:_____________________________
                                               Name: __________________________
                                               Title:  ________________________




































                                      -18-
<PAGE>
                                    EXHIBIT A
      CERTIFICATE OF DESIGNATION, PREFERENCES, AND RIGHTS OF SERIES Q STOCK
































                                      -19-
<PAGE>


                                    EXHIBIT B

                             SCHEDULE OF PURCHASERS




























                                      -20-
<PAGE>


                                    EXHIBIT C



                     [insert Registration Rights Agreement]
























                                      -21-
<PAGE>


                                    EXHIBIT D

The Company's legal counsel (as indicated) shall deliver to the Purchasers a
legal opinion as of the closing date to the effect that:

(i)      The Company is a corporation validly existing and in good standing
         under the laws of the State of Delaware; the Company has all requisite
         corporate power and authority to own, lease, license and operate its
         assets and properties and conduct its business as now being conducted
         and as described in the Information Documents.

(ii)     The Company has the requisite corporate power and authority to enter
         into and perform its obligations under the Transaction Documents, and
         to issue the Shares and upon conversion of the Shares, to issue the
         Conversion Shares. The execution and delivery of the Transaction
         Documents, and the execution, issuance and delivery of the Shares and
         the Conversion Shares by the Company and the consummation by it of the
         transactions contemplated thereby have been duly authorized by all
         necessary corporate action and no further consent or authorization of
         the Company or its Board of Directors or stockholders is required. Each
         of the Transaction Documents has been duly executed and delivered and
         constitutes a valid and binding obligation of the Company enforceable
         against the Company in accordance with it respective terms, except as
         such enforceability may be limited by applicable bankruptcy,
         insolvency, or similar laws relating to, or affecting generally the
         enforcement of, creditors' rights and remedies or by other equitable
         principles of general application.

(iii)    The execution, delivery and performance of the Transaction Documents by
         the Company and the consummation by the Company of the transactions
         contemplated thereby, including, without limitation, the issuance of
         the Shares and the Conversion Shares, do not and will not (i) result in
         a violation of the Company's Certificate of Incorporation or By-Laws or
         (ii) result in a violation of any U.S. federal or state law, rule or
         regulation applicable to the Company or by which any property or asset
         of the Company is bound or affected, except for such violations as
         would not, individually or in the aggregate, have a Material Adverse
         Effect.

(iv)     The issuance of the Shares and the Conversion Shares in accordance with
         the Agreement will be exempt from registration under the Securities Act
         of 1933. When so issued, subject to sufficient reserved authorized
         shares of Common Stock, the Shares and the Conversion Shares will be
         duly and validly issued, fully paid and nonassessable, and free of any
         liens, encumbrances and preemptive or similar rights contained in the
         Company's Certificate of Incorporation or Bylaws or, to our knowledge,
         in any agreement to which the Company is party.

(v)      The authorized capital stock of the Company consists of 225,000,000
         shares of Common Stock, $0.01 par value per share, and 10,000,000
         shares of Preferred Stock, par value $0.01 per share.

(vi)     No consent, approval, authorization, or order of any court or
         governmental authority or agency is required for the consummation by
         the Company of the transactions contemplated by the Agreement, except
         such as may be required by Regulation D promulgated by the Securities
         and Exchange Commission or state securities or "blue sky" laws.

                                      -22-
<PAGE>

                                   APPENDIX I


                             ABLE LABORATORIES, INC.
                         STOCK CERTIFICATE QUESTIONNAIRE

Pursuant to Section 3 of the Agreement, please provide us with the following
information:

1.       The exact name that your Shares are to be registered in (this is the
         name that will appear on your stock certificate(s)). You may use a
         nominee name if appropriate:

         -----------------------------------

2.       The relationship between the Purchaser of the Shares and the Registered
         Holder listed in response to item 1 above:

         -----------------------------------

3.       The mailing address of the Registered Holder listed in response to item
         1 above:

         -----------------------------------
         -----------------------------------
         -----------------------------------

4.       The Social Security Number or Tax Identification Number of the
         Registered Holder listed in response to item 1 above:

         -----------------------------------



                                      -23-
<PAGE>

                                   APPENDIX II


                                                       ABLE LABORATORIES, INC.

                      REGISTRATION STATEMENT QUESTIONNAIRE

           In connection with the preparation of the Registration Statement,
please provide us with the following information:

           1. Pursuant to the "Selling Shareholder" section of the Registration
Statement, please state your or your organization's address and name exactly as
it should appear in the Registration Statement:

                     -----------------------------------
                     -----------------------------------
                     -----------------------------------

           2. Please provide the number of Shares of Common Stock that you or
your organization will own immediately after Closing, including those Shares
purchased by you or your organization pursuant to this Purchase Agreement and
those Shares of Common Stock purchased by you or your organization through other
transactions:

                     -----------------------------------
                     -----------------------------------
                     -----------------------------------

           3. Have you or your organization had any position, office or other
material relationship within the past three (3) years with the Company or its
affiliates? Please circle the correct answer.

                     Yes                  No

           If yes, please indicate the nature of any such relationships below:

                     -----------------------------------
                     -----------------------------------
                     -----------------------------------

           4. Does the plan of distribution in the draft form of Registration
Statement provided to you reflect your current plan of distribution?

                     Yes                  No

           If no, please attach a copy of your current plan of distribution.

                                      -24-